SG Americas Securities’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
AC
EC
VPC
EAM
SG Americas Securities's VYGR Position: Q2 2025 in Review
SG Americas Securities sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 16,568 shares — an estimated $56K sold.
SG Americas Securities first reported a position in VYGR in Q3 2016 and held it in 16 quarters. The position peaked at $1.49M in Q2 2019. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.
- SG Americas Securities reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 16,568 Voyager Therapeutics shares in Q2 2025, an estimated $56K.
- SG Americas Securities first reported a position in Voyager Therapeutics in Q3 2016 and held it in 16 quarters.
- SG Americas Securities's Voyager Therapeutics position peaked at $1.49M in Q2 2019.
- 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.